CSIMarket
X4 Pharmaceuticals Inc  (XFOR)
Other Ticker:  
 
 

X4 Pharmaceuticals Inc's Yearly Capital Expenditures Growth 5 Years

 

Select the Comparisons : Select the Ratio:



XFOR Annual Capital Expenditures Growth

2022
2021
2020
2019
2018
Y / Y Annual Capital Expenditures Change -83.25 % -54.85 % 682.76 % 411.76 % -
Annual Capital Expenditures (in millions $) $0.10 $0.62 $1.36 $0.17 $0.03


Annual Capital Expenditures Growth Comment
X4 Pharmaceuticals Inc experienced detoriation of Annual Capital Expenditures for the fiscal year ended 2022 by -83.25% to $ 0.10 millions, compare to $ 0.62 in Annual Capital Expenditures reported in the previous year. The decline in company's annual Capital Expenditures accelerated, from the -54.85 % decrease, in the fiscal year ended 2021.

X4 Pharmaceuticals Inc Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2022 Annual Capital Expenditures within Healthcare SectorY/Y Capital Expenditures Growth %2022 Annual Capital Expenditures
Atreca inc 0.00 %$ 0.885  millions

Other Companies within Healthcare Sector and their 2022 Capital Expenditures

Y/Y Annual Capital Expenditures Growth %

2022 Capital Expenditures





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com